Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 4/20 | 0.56 |
| ▸ | ROCK2 | O75116 | 7/20 | 0.54 |
| ▸ | ROCK1 | Q13464 | 5/20 | 0.54 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.51 |
| ▸ | ACHE | P22303 | 4/20 | 0.50 |
| ▸ | BCHE | P06276 | 2/20 | 0.50 |
| ▸ | BACE1 | P56817 | 2/20 | 0.50 |
| ▸ | CCR2 | P41597 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
| ▸ | JAK1 | P23458 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12846292 | 0.93 | ROCK2 (0.56) | MCHR1ROCK2ROCK1CCR2 | |
| SCHEMBL12845958 | 0.82 | ACHE (0.54) | MCHR1ROCK2ROCK1ACHEBCHE | |
| SCHEMBL12846004 | 0.79 | ACHE (0.59) | ROCK2ROCK1ACHEBCHEKMT2A | |
| SCHEMBL12786027 | 0.79 | CYP2D6 (0.45) | MCHR1ROCK2ROCK1 | |
| SCHEMBL19500904 | 0.79 | MCHR1 (0.77) | MCHR1ROCK2ROCK1ACHECCR2 | |
| SCHEMBL12846289 | 0.78 | LMNA (0.54) | MCHR1ROCK2ROCK1MALT1ACHE | |
| SCHEMBL12845957 | 0.77 | MCHR1 (0.56) | MCHR1LMNAHTTKMT2A | |
| SCHEMBL12846294 | 0.76 | EHMT2 (0.58) | LMNAMAPTHTTKMT2AOPRK1 | |
| SCHEMBL331018 | 0.76 | BCHE (0.68) | ROCK2ROCK1MALT1ACHEBCHE | |
| SCHEMBL331017 | 0.76 | BCHE (0.68) | ROCK2ROCK1MALT1ACHEBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150072972-A1 | PHTHALAZINE DERIVATIVES AS PARP INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2015-03-12 | — | — | US | disclosed |
| US-8946221-B2 | Phthalazine derivatives as PARP inhibitors | JANSSEN PHARMACEUTICA, NV (BE) | 2015-02-03 | — | — | US | disclosed |
| US-20110065684-A1 | PHTHALAZINE DERIVATIVES AS PARP INHIBITORS | MEVELLEC LAURENCE ANNE | 2011-03-17 | — | — | US | disclosed |
| US-7803795-B2 | Phthalazine derivatives as parp inhibitors | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-09-28 | — | — | US | disclosed |
| US-7803795-B2 | Phthalazine derivatives as parp inhibitors | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-09-28 | — | — | US | disclosed |
| US-20080139568-A1 | Phthalazine Derivatives as Parp Inhibitors | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-06-12 | — | — | US | disclosed |
| US-20080139568-A1 | Phthalazine Derivatives as Parp Inhibitors | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150072972-A1 | PHTHALAZINE DERIVATIVES AS PARP INHIBITORS | PARP1, PARP2, PARP11 | MCHR1 4363/4885ROCK2 1136/4885ROCK1 1347/4885 |
| US-20080139568-A1 | Phthalazine Derivatives as Parp Inhibitors | PARP1, PARP2, PARP11 | MCHR1 4376/4885ROCK2 1144/4885ROCK1 1345/4885 |
| US-20110065684-A1 | PHTHALAZINE DERIVATIVES AS PARP INHIBITORS | PARP1, PARP2, PARP11 | MCHR1 4363/4885ROCK2 1136/4885ROCK1 1347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.